Nouvelle déclaration d'incident
No de la demande: 2021-4866
Numéro de référence du titulaire d'homologation: 2021-CA-000070
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G 5L3
Incident chez un animal domestique
Pays: CANADA
État: ONTARIO
Inconnu
ARLA No d'homologation 21744 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Zodiac Flea and Tick Spray for Dogs and Cats, 475 mL
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
Unknown
1
Femme
Inconnu
Inconnu
Cutanée
Unknown / Inconnu
Unknown / Inconnu
Système
Unknown / Inconnu
Oui
Oui
Inconnu
Unknown/Inconnu
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 11 Apr 2021, the animal owner purchased the product online. On an unknown date, the animal owner applied the product topically to the cat in an extra-labelled, though unspecified, manner. On an unknown date following product application, the cat developed symptoms. The cat was hospitalized for an unspecified duration during which unspecified blood work and treatments were performed. The cat was discharged on three unspecified medications. Symptoms persist. Report was made via email with limited information, and no further information is expected.
Modérée
Assessment: This product has a wide margin of safety. There is risk of irritation including dermal and GI (if ingested). GI signs can include drooling due to a taste reaction and vomiting due to GI irritation. Pain and seizures are not expected. Other causes should be considered including underlying disease and exposure to higher concentration permethrin products intended for canine use. Further information including timeline of the product applications and development / progression of clinical signs, veterinary examination findings, blood work results, and response to treatment may have been able to provide further information about the cause of symptoms, but these were not reported. The information contained in this report is based on self-reported statements provided to the registrant during email correspondence. These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the email correspondence.